XML 45 R37.htm IDEA: XBRL DOCUMENT v3.23.2
Sale of Freeline Therapeutics GmbH - Summary of Company's Book Value of Assets And Liabilities Sold (Details) - USD ($)
$ in Thousands
6 Months Ended
Feb. 08, 2023
Jun. 30, 2023
Dec. 31, 2022
Book value of liabilities sold      
Amounts attributable to liabilities sold     $ 10,337
Less: accumulated other comprehensive loss   $ (784) $ (3,151)
Gain on sale of Freeline Therapeutics GmbH   $ 20,279  
Freeline Therapeutics Gmbh      
Book value of assets sold      
Cash and cash equivalents $ 1,015    
Prepaid expenses and other current assets 414    
Property and equipment, net 5,470    
Operating lease right of use assets 8,455    
Other non-current assets 3    
Amounts attributable to assets sold 15,357    
Book value of liabilities sold      
Accounts payable 230    
Accrued expenses and other current liabilities 1,430    
Operating lease liabilities, current 869    
Operating lease liabilities, non-current 8,044    
Amounts attributable to liabilities sold 10,573    
Total identifiable net assets sold 4,784    
Less: accumulated other comprehensive loss (155)    
Consideration, inclusive of cash transferred 25,218    
Gain on sale of Freeline Therapeutics GmbH $ 20,279